The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Evaluation of the genomic and immune profiles of patients with lung adenosquamous carcinoma (LUAS) and association of response to treatment.
 
Matthew Lee
No Relationships to Disclose
 
Tolulope Tosin Adeyelu
Employment - Caris Life Sciences
 
Shuai Wang
No Relationships to Disclose
 
Andrew Elliott
Employment - Caris Life Sciences
 
Ari M. Vanderwalde
Employment - Caris Life Sciences
Consulting or Advisory Role - George Clincal; West Clinic
Research Funding - Amgen (Inst); AstraZeneca (Inst); Bristol-Myers Squibb (Inst); Caris Life Sciences (Inst); EMD Serono (Inst); Genentech/Roche (Inst); Immunomedics/Gilead (Inst); Lilly (Inst); Merck (Inst); Millennium (Inst); Replimune (Inst)
 
Liza C Villaruz
Consulting or Advisory Role - Bristol-Myers Squibb/Celgene; Daiichi Sankyo/Astra Zeneca; EMD Serono; Gilead Sciences; Janssen Oncology; Jazz Pharmaceuticals; Johnson & Johnson/Janssen; Sanofi/Regeneron; Takeda
Research Funding - AstraZeneca (Inst); BioAtla (Inst); BMS (Inst); Genentech (Inst); GlaxoSmithKline (Inst); Incyte (Inst); Jazz Pharmaceuticals (Inst); Lilly (Inst); Merck (Inst); Regeneron (Inst)
 
Hina Khan
Consulting or Advisory Role - Genzyme
Research Funding - Robert A. Winn Diversity in Clinical Trials Award Program
 
Benjamin Herzberg
Honoraria - Boxer Capital; Eisai; OncLive/MJH Life Sciences
Consulting or Advisory Role - Amgen; Astellas Pharma; AstraZeneca
Research Funding - Amgen (Inst); Astellas Pharma (Inst); AstraZeneca; IDEAYA Biosciences (Inst); Monte Rosa Therapeutics (Inst); Prelude Therapeutics (Inst); Repare Therapeutics (Inst); Revolution Medicines (Inst); Seagen (Inst)
 
So Yeon Kim
Consulting or Advisory Role - Amgen
Research Funding - Boehringer Ingelheim (Inst); Genmab (Inst); Loxo/Lilly (Inst)
 
Patrick C. Ma
Honoraria - AstraZeneca; BeiGene
Research Funding - Abbvie (Inst); Apollomics (Inst); AstraZeneca (Inst); BeiGene (Inst); Bristol-Myers Squibb (Inst); Calithera Biosciences (Inst); Elevation Oncology (Inst); Genmab (Inst); Merck (Inst); Mirati Therapeutics (Inst); OncoC4 (Inst); Roche/Genentech (Inst)
 
Stephen V. Liu
Consulting or Advisory Role - Abbvie; Amgen; AstraZeneca; Boehringer Ingelheim; Bristol-Myers Squibb; Candel Therapeutics; Catalyst Pharmaceuticals; Daiichi Sankyo/UCB Japan; Elevation Oncology; Genentech; Gilead Sciences; Guardant Health; Janssen Oncology; Jazz Pharmaceuticals; Merus; Mirati Therapeutics; MSD Oncology; Novartis; Pfizer; RAPT Therapeutics; Regeneron; Revolution Medicines; Sanofi; Takeda
Research Funding - Abbvie (Inst); Alkermes (Inst); Elevation Oncology (Inst); Ellipses Pharma (Inst); Genentech/Roche (Inst); Gilead Sciences (Inst); Merck (Inst); Merus (Inst); Nuvalent, Inc. (Inst); OSE Immunotherapeutics (Inst); Puma Biotechnology (Inst); RAPT Therapeutics (Inst); Turning Point Therapeutics (Inst)
 
Balazs Halmos
Consulting or Advisory Role - Apollomics; Arcus Biosciences; AstraZeneca; Bayer; BeiGene; Bristol-Myers Squibb; Daiichi Sankyo/Lilly; Genentech/Roche; Janssen Oncology; Lilly; Merck; merus; Novartis; Pfizer; Takeda; Turning Point Therapeutics; Veracyte
Research Funding - Abbvie (Inst); Advaxis (Inst); Amgen; AstraZeneca (Inst); Black Diamond Therapeutics (Inst); Blueprint Medicines (Inst); Boehringer Ingelheim (Inst); Bristol-Myers Squibb (Inst); Daiichi Sankyo/Astra Zeneca (Inst); Elevation Oncology (Inst); Forward (Inst); GlaxoSmithKline (Inst); Janssen Oncology (Inst); Jazz Pharmaceuticals (Inst); Merck (Inst); Mirati Therapeutics (Inst); Novartis (Inst); Pfizer (Inst); Regeneron (Inst); Roche/Genentech (Inst); Takeda (Inst); Tesaro/GSK (Inst)
 
Haiying Cheng
Consulting or Advisory Role - G1 therapeutics; Janssen
Research Funding - AstraZeneca (Inst); Roche/Genentech (Inst)
Patents, Royalties, Other Intellectual Property - Pat pending